FDA approves Ozempic for cardiovascular risk reduction in adults with type 2 diabetes and known heart disease, updates Rybelsus label [Press release], Novo Nordisk (2020) Safety of semaglutide, Frontiers in Endocrinology (2021) Ozempic label, Novo Nordisk (2023) Bruising: A neglected, though patient-relevant complication of insulin injections coming to light from a real-life nationwide survey, Diabetes Therapy (2021) Using your Ozempic pen, Novo Nordisk Effect of cold application on bruising and pain following Heparin subcutaneous injection: a systematic review and meta-analysis, Journal of Nursing Scholarship (2020) Effect of cold application and compression on pain and bruising in subcutaneous heparin injection, Journal of Vascular Nursing (2023) Oral semaglutide, Clinical Diabetes (2020) Daily oral GLP-1 receptor agonist orforglipron for adults with obesity, The New England Journal of Medicine (2023) Oral and injectable medications for Type 2 diabetes, American Diabetes Association Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Incorporate Beneficial Fats (Specifically MUFAs) The Science: For a long time, dietary fat was misunderstood in the context of satiety, but we now know that the type of fat you choose matters so much for hormonal signaling and health
In contrast to RCTs, retrospective observational studies offer the benefit of capturing extensive patient data in real-world settings
Frequently Asked Questions What is the recommended starting dose for retatrutide
"When FDA-approved drugs are available, outsourcing facilities cannot lawfully compound using bulk drug substances unless there is a clear clinical need," FDA Commissioner Marty Makary stated in the agency's announcement
Even with initial uncertainties, the research community is excited about the potential uses of GLP-1s for treating mental health
